From Wuhan to San Diego—How a mutation on the novel coronavirus has come to dominate the globe

Two variants of the novel coronavirus (SARS-CoV-2), called G614 and D614, were circulating in mid-March. A new study shows that the G version of the virus has come to dominate cases around the world. They report that this mutation does not make...
2-Jul-2020 12:05 PM EDT Add to Favorites

Even in the worst COVID-19 cases, the body launches immune cells to fight back

SHAREInternational collaboration provides important piece of COVID-19 puzzleLA JOLLA—A new study from researchers at La Jolla Institute for Immunology (LJI) and Erasmus University Medical Center (Erasmus MC) shows that even the sickest COVID-19...
29-Jun-2020 12:25 PM EDT Add to Favorites

LJI Scientists Investigate a Powerful Protein Behind Antibody Development

Scientists at the La Jolla Institute for Immunology (LJI) have discovered a potential new way to better fight a range of infectious diseases, cancers and even autoimmune diseases. The new study, published recently in Nature Immunology, shows how a...
17-Jun-2020 4:35 PM EDT Add to Favorites

LJI scientists uncover immune cells that may lower airway allergy and asthma risk

In a new Science Immunology study, published on June 12, 2020, scientists at La Jolla Institute for Immunology (LJI) offer a clue to why non-allergic people don’t have a strong reaction to house dust mites. They’ve uncovered a previously unknown...
10-Jun-2020 5:05 PM EDT Add to Favorites

Fighting Mosquito-Borne Viruses Requires a Precise Balance of Immune Cells

In a new study, published June 5, 2020, in the Journal of Experimental Medicine, scientists at La Jolla Institute for Immunology (LJI) shows that antibodies against JEV are “cross-reactive” and can also recognize Zika virus. Unfortunately, these...
4-Jun-2020 2:35 PM EDT Add to Favorites

What we can learn from SARS

Seventeen years ago, another viral outbreak was in the news. People wore masks, many were nervous to fly. This outbreak, known as SARS, was caused by a type of coronavirus we now call SARS-CoV-1. The difference was that SARS-CoV-1 was controlled and...
22-May-2020 12:55 PM EDT Add to Favorites

First detailed analysis of immune response to SARS-CoV-2 bodes well for COVID-19 vaccine development

A study by researchers at La Jolla Institute for Immunology documents a robust antiviral immune response to SARS-CoV-2 in a group of 20 adults who had recovered from COVID-19. The findings show that the body’s immune system is able to recognize...
14-May-2020 6:05 PM EDT Add to Favorites

New research gives further evidence that autoimmunity plays a role in Parkinson’s disease

A new study co-led by scientists at the La Jolla Institute for Immunology (LJI) adds increasing evidence that Parkinson’s disease is partly an autoimmune disease. In fact, the researchers report that signs of autoimmunity can appear in...
17-Apr-2020 4:55 PM EDT Add to Favorites

See All News